Melanoma Clinical Trials in Austin

Showing 201-213 of 213 trials

High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma

NCT00003091

RATIONALE: Interferon alfa may interfere with the growth of cancer cells. Interleukin-2 may stimulate a person's white blood cells to kill kidney cancer or melanoma cells. PURPOSE: Phase II trial to study the effectiveness of high-dose interferon alfa and interleukin-2 in treating patients with metastatic kidney cancer or melanoma.

Kidney CancerMelanoma (Skin)

Hoag Memorial Hospital Presbyterian40 participantsStarted Jan 1996

Newport Beach, California, United States • Bloomington, Indiana, United States • Knoxville, Tennessee, United States +1 more locations

COMPLETEDPhase 2147 miles

CP-675,206 In Patients With Advanced Melanoma

NCT00086489

The purpose of this study is to assess the efficacy, safety, and tolerability of monoclonal antibody therapy using 2 regimens for the treatment of advanced melanoma

Malignant Melanoma

AstraZeneca118 participantsStarted Aug 2003

Los Angeles, California, United States • Tampa, Florida, United States • Chicago, Illinois, United States +6 more locations

COMPLETEDPhase 3147 miles

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

NCT00518895

This study is being performed to prospectively determine whether dacarbazine plus Genasense is significantly better than dacarbazine plus placebo in chemotherapy-naive patients with advanced melanoma and low baseline LDH (LDH less than or equal to 0.8 times the upper limit of normal). LDH is a biomarker strongly associated with improved outcomes in a recent trial of dacarbazine plus Genasense.

Melanoma

Genta Incorporated300 participantsStarted Jul 2007

Mobile, Alabama, United States • Encinitas, California, United States • Santa Rosa, California, United States +74 more locations

High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma

CP-675,206 In Patients With Advanced Melanoma

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

Melanoma Trials in Other Cities

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Vaccine Therapy for Patients With Stage IV Melanoma

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

Study of XL281 in Adults With Solid Tumors

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

Study of CP-675,206 in Refractory Melanoma

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

Other Conditions in Austin